They may be isolated findings or part of inherited diseases such as nail-patella syndrome or Iso-Kikuchi syndrome, or secondary to exposure to teratogens during pregnancy, such as phenytoin, warfarin, or alcohol.3,5,6,1315 Pachyonychia congenita (PC) This corresponds to a group of autosomal dominant hereditary diseases caused by variants in the genes encoding keratins KRT6a, KRT6b, KRT6c, KRT16, and KRT17
More sensitive peptides benefit from the most stable temperature zones while robust peptides tolerate less optimal locations
FDA policy and enforcement around compounded drugs that resemble FDA-approved GLP-1 medicines can evolve as supply conditions change
Confirm availability during your consultation
The future of GLP 1 therapy for women is not about higher doses or faster results